• Citer

Switching to biphasic insulin aspart 30/50/70 from biphasic human insulin 30/50 in patients with type 2 diabetes in normal clinical practice: observational study results.

par Nobels, Frank;D'Hooge, Dirk;Crenier, Laurent
Référence Current medical research and opinion, 28, 6, page (1017-1026)
Publication Publié, 2012-06

Article révisé par les pairs

• Détails
• Contenu

Résumé :

To investigate the safety and efficacy of switching to biphasic insulin aspart (BIAsp) 30, 50 or 70 in patients with type 2 diabetes previously treated with biphasic human insulin (BHI) 30/50 (with or without oral glucose-lowering drugs) in routine clinical practice.